Evaluation of and quality assurance in HER2 analysis in breast carcinomas from patients registered in Danish Breast Cancer Group (DBCG) in the period of 2002-2006. A nationwide study including correlation between HER-2 status and other prognostic variables

Author： Bruun Rasmussen Birgitte   Andersson Michael   Christensen Ib   Møller Susanne  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.47, Iss.4, 2008-01, pp. : 784-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Gelatinase Levels in Patients with Primary Breast Cancer in Relation to Axillary Lymph Node Status, Her2/neu Expression and other Clinicopathological Variables

By Decock J.   Hendrickx W.   Wildiers H.   Christiaens M.   Neven P.   Drijkoningen M.   Paridaens R.  

Clinical and Experimental Metastasis, Vol. 22, Iss. 6, 2005-11 ,pp. : 495-502

Springer Publishing Company

Access to resources Recommend Favorite

HER2 as a prognostic and predictive marker for breast cancer

By Cooke T.   Reeves J.   Lanigan A.   Stanton P.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

By Kostopoulos Ioannis   Arapantoni-Dadioti Petroula   Gogas Helen   Papadopoulos Savvas   Malamou-Mitsi Vasiliki   Scopa Chrisoula   Markaki Sofia   Karagianni Evangelia   Kyriakou Vasiliki   Margariti Anastasia   Kyrkou Elisavet   Pavlakis Kitty   Zaramboukas Thomas   Skordalaki Anna   Bourli Antonia   Markopoulos Christos   Pectasides Dimitrios   Dimopoulos Meletios   Skarlos Dimosthenis   Fountzilas George  

Breast Cancer Research and Treatment, Vol. 96, Iss. 3, 2006-04 ,pp. : 251-261

Springer Publishing Company

Access to resources Recommend Favorite

Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow

By Schindlbeck C.   Janni W.   Shabani N.   Rack B.   Gerber B.   Schmitt M.   Harbeck N.   Sommer H.   Braun S.   Friese K.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 65-74

Springer Publishing Company

Access to resources Recommend Favorite

A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer

By Vrou Offersen Birgitte   Alsner Jan   Ege Olsen Karen   Riisbro Rikke   Brunner Nils   Brandt Sørensen Flemming   Sandahl Sørensen Boe   Olrik Schlemmer Birgitte   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 618-632

Informa Healthcare

Access to resources Recommend Favorite